Construction of attenuated HIV-1 accessory gene immunization cassettes

Vaccine

Volumn 16, Issue 19, 1998, Pages 1872-1879

  Ayyavoo, V ^a   Nagashunmugam, T ^a   Phung, M T ^a   Buckner, C ^a   Kudckodkar, S ^a   Le, P ^a   Reddy, P J ^a   Santiago, L ^a   Patel, M ^a   Tea, L ^a   Weiner, D B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cassettes; Gene; HIV 1; Immunization

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE;

ANIMAL EXPERIMENT; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; DRUG DESIGN; GENE CASSETTE; GENE EXPRESSION; GENE SEQUENCE; GENE THERAPY; HUMORAL IMMUNITY; IMMUNIZATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AIDS VACCINES; ANIMALS; CELL LINE; CYTOKINES; GENES, NEF; GENES, REGULATOR; GENES, VIF; GENES, VIRAL; GENES, VPU; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MUTAGENESIS, INSERTIONAL; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, ATTENUATED; VACCINES, DNA; VARIATION (GENETICS);

EID: 18244423667     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00172-8     Document Type: Conference Paper

References (37)

1. 1 Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C. and Robinson, H. L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 11478-11482.
2. 2 Tang, D., DeVit, M. and Johnston, S. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356, 152-154.
3. 3 Ulmer, J. B., Donnelly, J. and Parker, S. E. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749.
4. 4 Wang, B., Ugen, K. and Srikantan, V. et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 4156-4160.
5. 5 Wang, B., Boyer, J. and Ugen, K. E. et al. Nucleic acid-based immunization against HIV-1: induction of protective in vivo immune response. AIDS 1995, 9, S159-S170.
6. 6 Kim, J., Weiner, D. B. DNA/genetic vaccination for HIV. Springer Seminars in Immunopathology, 1997, 19, 175-194.
7. 7 Fuller, D. H. and Haynes, J. R. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Human Retroviruses 1994, 11, 1433-1441.
8. 8 Lu, S., Santoro, J. C., Fuller, D. H., Haynes, J. R. and Robinson, H. L. Use of DNAs expressing HIV-1 env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 1995, 209, 147-154.
9. 9 Boyer, J. D., Ugen, K. E. and Wang, B. et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med. 1997, 3, 526-532.
10. 10 Cullen, B. R. and Greene, W. C. Regulatory pathways governing HIV-1 replication. Cell 1989, 58, 423-426.
11. 11 Desrosiers, R. C. HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res. Human Retroviruses 1992, 8, 411-412.
12. 12 Gabuzda, D. H., Lawrence, K. and Langhoff, E. et al. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 1992, 66, 6489-6495.
13. 13 Gibbs, J. S., Regier, D. A. and Desrosiers, R. C. Construction and in vitro properties of HIV-1 mutants with deletions in nonessential genes. AIDS Res. Human Retroviruses 1994, 10, 343-350.
14. 14 Aldrovandi, G. M. and Zack, J. A. Replication and pathogenicity of Human Immunodeficiency Virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 1996, 70, 1505-1511.
15. 15 Trono, D. HIV accessory proteins: leading roles for the supporting cast. Cell 1995, 82, 189-192.
16. 16 Ameisen, J. C., Guy, B., Loche, M., Chamaret, S., Mouton, Y. and Capron, A. Antibody response to the HIV-1 regulatory gene products nef, vif and vpr in HIV-1 infected seronegative individuals. Int. Conf. AIDS 1989, 5, 533.
17. 17 Lamhamedi-Cherradi, S., Culmann-Penciolelli, B. and Guy, B. et al. Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS 1992, 6, 1249-1258.
18. 18 Velpandi, A., Ugen, K. E. and Fernandes, L. et al. Analysis of genetic heterogeneity, antigenicity and biological characteristcs of HIV-1 in a maternal transmitter and non-transmitter patient pair. DNA Cell Biol. 1996, 15, 571-580.
19. 19 Kim, J., Ayyavoo, V. and Bagarazzi, M. L. et al. In vivo engeineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 1997, 158, 816-826.
20. 20 Mahalingam, S., Mamata, P., Collman, R. G. and Srinivasan, A. The carboxy terminal domain is essential for stability not for virion incorporation of HIV-1 vpr into virus particles. Virology 1995, 214, 647-652.
21. Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization. DNA Cell Biol. 1996, 15, 353-361.
22. 22 Meyerhans, A., Cheynier, R. and Albert, J. et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989, 58, 901-910.
23. 23 Delassus, S., Cheynier, R. and Wain-Hobson, S. Evolution of Human Immunodeficiency Virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J. Virol. 1991, 65, 225-231.
24. 24 Pircher, H., Moskphidis, D., Rohrer, U., Burki, K., Hengartner, H. and Zinkernagel, R. M. Viral escape by selection of cytotoxic T cell resistant variants in vivo. Nature 1990, 346, 629-633.
25. 25 Reitz, M. S., Wilson, C., Naugle, C., Gallo, R. C. and Robert-Guroff, M. Generation of a neutralization resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell 1988, 54, 57-63.
26. 26 Sova, P., ranst, M. and Gupta, P. et al. Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. J. Virol. 1995, 69, 2557-2564.
27. 27 Volsky, D. J., Potash, M. J. and Simm, M. et al. The Human Immunodeficiency Virus Type 1 vif gene: the road from an accessory to an essential role in human immunodeficiency virus type 1 replication. Curr. Topics in Micro. Immunol. 1995, 193, 157-168.
28. 28 Michael, N. L., Chang, G. and D'Arcy, L. A. et al. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J. Virol. 1995, 69, 4228-4236.
29. 29 Hammes, S. R., Dixon, E. P., Malim, M. H., Cullen, B. R. and Greene, W. C. Nef protein of human immunodeficiency virus type 1 : evidence against its role as a transcriptional inhibitor. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 9549-9553.
30. 30 Kim, S., Ikeuchi, K., Byrn, R., Groopman, J. and Baltimore, D. Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 9544-9548.
31. 31 Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E. and Trono, D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994, 76, 853-864.
32. 32 Rhee, S. and Marsh, J. W. Human Immunodeficiency Virus Type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 1994, 68, 5156-5163.
33. 33 Culmann-Penciolelli, B., Lamhamedi-Cherradi, S. and Couillin, I. et al. Identification of multirestricted immunodominat regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein. J. Virol. 1994, 68, 7336-7343.
34. 34 Greenough, T. C., Somasundaran, M. and Brettler, D. B. et al. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res. Human Retroviruses 1994, 10, 395-403.
35. 35 Harrer, T., Harrer, E. and Kalams, S. A. et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J. Immunol. 1996, 156, 2616-2623.
36. 36 Gately, M. K., Wolitzky, A. G., Quinn, P. M. and Chizzonite, R. Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 1992, 143, 127-142.
37. 37 Robertson, M. J., Soiffer, R. J. and Wolf, S. F. et al. Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 1992, 175, 779-788.